Bentley Pharmaceuticals to Host Second Quarter Results Conference Call and Webcast on Wednesday, July 28, 2004

Bentley Pharmaceuticals to Host Second Quarter Results Conference
Call and Webcast on Wednesday, July 28, 2004 


EXETER, N.H., July 21  /PRNewswire-FirstCall/ -- Bentley Pharmaceuticals, Inc.
(NYSE:BNT), a technology-based specialty pharmaceutical and drug delivery
company with a growing branded and generic product line in Europe, today
announced that it will release its 2004 second quarter results for the three
and six months ended June 30, 2004 before the open of the market on Wednesday,
July 28, 2004.

Management will host a conference call to discuss these results at 10:00 a.m.
Eastern Daylight Savings Time on that day. To participate on the call within
the U.S. and Canada, please dial [phone] approximately 10 minutes prior
to the scheduled start time and give the password "BENTLEY." International
participants may dial [phone]; the password is the same. The conference
will also be broadcast live on the Internet and may be accessed via the
Company's web site, http://www.bentleypharm.com/. A replay of the conference
call will be available through August 4, 2004. Listeners may access the replay
via the Company's website, http://www.bentleypharm.com/, or by dialing (800)
642-1687 from within the U.S. and Canada and using access code 8816411. A
replay of the conference call from international locations may be accessed by
dialing [phone] using the same access code.

Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on
advanced drug delivery technologies and pharmaceutical products. Bentley's
proprietary drug technologies enhance or facilitate the absorption of
pharmaceutical compounds across various membranes. Bentley also manufactures
and markets a growing portfolio of generic and branded pharmaceuticals in
Europe for the treatment of cardiovascular, gastrointestinal, infectious and
neurological diseases through its subsidiaries, Laboratorios Belmac,
Laboratorios Davur and Laboratorios Rimafar; and manufactures and sells active
pharmaceutical ingredients through its subsidiary, Bentley API.

Copies of Bentley Pharmaceuticals' press releases and other information may be
obtained through Bentley's web site at http://www.bentleypharm.com/. 

DATASOURCE: Bentley Pharmaceuticals, Inc.



CONTACT:  Michael D. Price, Vice President, Chief Financial Officer of

Bentley Pharmaceuticals, Inc., [phone]; or Investor Relations -

Jonathan Birt, Lanie Marcus, or Sean Leous of Financial Dynamics,

[phone], for Bentley Pharmaceuticals, Inc.



Web site:  http://www.bentleypharm.com/ 

Copyright